Giraudon , I., Abel-Ollo, K., Vanaga-Arāja, D., Heudtlass, P. and Griffiths, P., N. (2024). Nitazenes represent a growing threat to public health in Europe. The Lancet Public Health, 9, (4), pp. e216. doi:10.1016/S2468-2667(24)00024-0 [RJ] View web page
Soderholm, A., Mansfield, D., Groshkova, T., Sedefov, R. and Griffiths, P., N. (2024). Commentary on Pardo et al.: Whatever the past situation, drug precursor chemicals may in future represent an important source for synthetic drug production in Afghanistan and surrounding countries. Addiction, 119, (6), pp. 1021-1023. doi:10.1111/add.16496 [RJ] View web page
Griffiths, P., N., Seyler, T., De Morais, J., M., Mounteney, J. and Sedefov, R. (2023). Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the future. Addiction, 119, (8). doi:10.1111/add.16420 [RJ] View web page
Singleton, N., Cunningham, A., Groshkova, T., Royuela, L., Sedefov, R. and Griffiths, P., N. (2023). Using Supply Indicators in the Evaluation of Drug Supply Reduction – Challenges and Opportunities. In Rossi, C. and Conti, S. (eds.) Evaluating the impact of Laws Regulating Illicit Drugs on Health and Society. Bentham Science Publisher. pp. 134-152. doi:10.2174/9789815079241123010012 [CH] View web page
Lorenzetti, V., Hindocha, C., Petrilli, K., Griffiths, P., N., Brown, J., Castillo-Carniglia, Á., Caulkins, J., P., Englund, A., Elsohly, M., A., Gage, S., H., Groshkova, T., Gual, A., Hammond, D., Lawn, W., Lopez, H., Manthey, J., Mokrysz, C., Liccardo Pacula, R., Van Laar, M., Vandrey, R., Wadsworth, E., Winstock, A., R., Hall, W., Curran, H., V. and Freeman, T., P. (2022). The iCannToolkit: a consensus‐based, flexible framework for measuring contemporary cannabis use. Addiction, 117, (9), pp. 2558-2560. doi:10.1111/add.15956 [RJ] View web page
Lorenzetti, V., Hindocha, C., Petrilli, K., Griffiths, P., N., Brown, J., Castillo-Carniglia, Á., Caulkins, J., P., Englund, A., Elsohly, M., A., Gage, S., H., Groshkova, T., Gual, A., Hammond, D., Lawn, W., Lopez, H., Manthey, J., Mokrysz, C., Pacula, R., Van Laar, M., Vandrey, R., Wadsworth, E., Winstock, A., R., Hall, W., Curran, H., V. and Freeman, T., P. (2022). The iCannToolkit: a tool to embrace measurement of medicinal and non‐medicinal cannabis use across licit, illicit and cross‐cultural settings. Addiction, 117, (6), pp. 1523-1525. doi:10.1111/add.15855 [RJ] View web page
Pirona, A., Matias, J., Montanari, L., Škařupová, K., Ferri, M., Giraudon , I., Mounteney, J., Sleiman, S., Natoniewska, K., Guarita, B., Vandam, L., Surmont, T. and Griffiths, P., N. (2022). Impact of COVID-19 on drug markets, use, harms and drug services in Europe. Journal of Geography Politics and Society, 12, (1). doi:10.26881/jpgs.2022.1.02 [RJ] View web page
Schneider, E., Bronzwaer, S., Catchpole, M., Cockburn, W., de Coen, W., Foltz, C., Goodey, J., Griffiths, P., N., Herold, R., Ikomonou, D., Jepsen, M., Raineri, A., Reingardé, J. and Uhel, R. (2022). Learning from the COVID-19 experience: Strengthening EU-ANSA Agencies' cooperation and preparedness to support evidence-based policymaking in times of crisis. Publications Office of the European Union. ISBN: 978-92-9499-407-3 doi:10.2805/402212 [T] View web page
Ferri, M. and Griffiths, P., N. (2021). Good Practice and Quality Standards. In el-Guebaly, N., Carrà, G., Galanter, M. and Baldacchino, A. (eds.) Textbook of Addiction Treatment. pp. 783-800. doi:10.1007/978-3-030-36391-8_54 [CH] View web page
Griffiths, P., N., Mounteney, J. and Sedefov, R. (2021). The same fundamental drivers but differently expressed: what can we learn from comparing the recent experiences with synthetic opioids in the US and Europe? Addiction, 116, (6), pp. 1314-1316. doi:10.1111/add.15340 [RJ] View web page
Groshkova, T., Liem, M., Cunningham, A., Sedefov, R. and Griffiths, P., N. (2021). Drug-related violence: Will COVID-19 drive better data for safer and more secure EU? International Journal of Drug Policy, 93. doi:10.1016/j.drugpo.2021.103143 [RJ] View web page
Guarita, B., Běláčková, V., van der Gouwe, D., Blankers, M., Pazitny, M. and Griffiths, P., N. (2021). Monitoring drug trends in the digital environment–New methods, challenges and the opportunities provided by automated approaches. International Journal of Drug Policy, 94. doi:10.1016/j.drugpo.2021.103210 [RJ] View web page
Hughes, B., Vandam, L., Mounteney, J. and Griffiths, P., N. (2021). Regulatory approaches to cannabidiol in the European Union: are market developments sowing the seeds of confusion? Addiction, 117, (1), pp. 3-4. doi:10.1111/add.15587 [RJ] View web page
Lorenzetti, V., Hindocha, C., Petrilli, K., Griffiths, P., N., Brown, J., Castillo-Carniglia, Á., Caulkins, J., P., Englund, A., Elsohly, M., A., Gage, S., H., Groshkova, T., Gual, A., Hammond, D., Lawn, W., Lopez, H., Manthey, J., Mokrysz, C., Pacula, R., Van Laar, M., Vandrey, R., Wadsworth, E., Winstock, A., R., Hall, W., Curran, H., V. and Freeman, T., P. (2021). The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use. Addiction, 117, (6), pp. 1510-1517. doi:10.1111/add.15702 [RJ] View web page
Seyler, T., Giraudon , I., Noor, A., Mounteney, J. and Griffiths, P., N. (2021). Is Europe facing an opioid epidemic: What does European monitoring data tell us? European Journal of Pain, 25, (5), pp. 1072-1080. doi:10.1002/ejp.1728 [RJ] View web page
Groshkova, T., Stoian, T., Cunningham, A., Griffiths, P., N., Singleton, N. and Sedefov, R. (2020). Will the Current COVID-19 Pandemic Impact on Long-term Cannabis Buying Practices? Journal of Addiction Medicine, 14, (4), pp. e13-e14. doi:10.1097/ADM.0000000000000698 [RJ] View web page
Degenhardt, L., Wolfe, D., Hall, W., Hickman, M., Chang, J., Bruneau, J., Farrell, M. and Griffiths, P., N. (2019). Strategies to reduce drug-related harm: responding to the evidence base. The Lancet, 394, (10208), pp. 1490-1493. doi:10.1016/S0140-6736(19)32232-9 [RJ] View web page
Ferri, M., Mounteney, J. and Griffiths, P., N. (2019). Low-risk drinking guidelines: a pragmatic approach to health promotion? Addiction, 114, (4), pp. 605-607. doi:10.1111/add.14532 [RJ] View web page
Freeman, T., P., Groshkova, T., Cunningham, A., Sedefov, R., Griffiths, P., N. and Lynskey, M. (2019). Increasing potency and price of cannabis in Europe, 2006‐2016. Addiction, 114, (6), pp. 1015-1023. doi:10.1111/add.14525 [RJ] View web page
Hines, L., Trickey, A., Leung, J., Larney, S., Peacock, A., Degenhardt, L., Colledge-Frisby, S., Hickman, M., Grebely, J., Cunningham, E., B., Stone, J., Dumchev, K., Griffiths, P., N., Vickerman, P., Mattick, R. and Lynskey, M. (2019). Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis. The Lancet Global Health, 8, (1), pp. e76-e91. doi:10.1016/S2214-109X(19)30462-0 [RJ] View web page
Leung, J., Peacock, A., Colledge-Frisby, S., Grebely, J., Cunningham, E., B., Hickman, M., Vickerman, P., Stone, J., Trickey, A., Dumchev, K., Lynskey, M., Hines, L., Griffiths, P., N., Mattick, R., Degenhardt, L. and Larney, S. (2019). A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs—Do Gender-Based Differences Vary by Country-Level Indicators? The Journal of Infectious Diseases, 220, (1), pp. 78-90. doi:10.1093/infdis/jiz058 [RJ] View web page
Mounteney, J. and Griffiths, P., N. (2019). Monitoring Trends: Use of Local Data. In Slobodin, O., Petras, H., Robertson, E. and Hingson, R. (eds.) Prevention of Substance Use. Springer Nature. pp. 223-232. doi:10.1007/978-3-030-00627-3_14 [CH] View web page
Mounteney, J., Griffiths, P., N., Sedefov, R. and Evans-Brown, M. (2019). Fentanils: a serious threat to public health. Addiction, 114, (5), pp. 783-785. doi:10.1111/add.14542 [RJ] View web page
Peacock, A., Bruno, R., Gisev, N., Degenhardt, L., Hall, W., Sedefov, R., White, J., Thomas, K., V., Farrell, M. and Griffiths, P., N. (2019). New psychoactive substances: challenges for drug surveillance, control, and public health responses. The Lancet, 394, (10209), pp. 1668-1684. doi:10.1016/S0140-6736(19)32231-7 [RJ] View web page
Singleton, N., Ballotta, D., Costa Storti, C., Quigley, E., Vandam, L. and Griffiths, P., N. (2019). Getting real: Lessons learnt from the EMCDDA’s experience of supporting real life policy evaluations. Journal of Addiction Research and Practice, 65, (5). doi:10.1024/0939-5911/a000627 [RJ] View web page
Catchpole, M., Cockburn, W., Comby, B., Deluyker, H., Eichler, H., Goodey, J., Griffiths, P., N., Hugas, M., Ikomonou, D., Knight, D., Mezger, E., Mortensen, L., Murphy, T., Needham, H., Purser, S., Ranieri, A., Schmidt-Abbey, B., Stanners, D. and Szcześniak, A. (2018). EU–ANSA agencies' engagement in the European Union research knowledge cycle: an overview. Publications Office of the European Union. ISBN: 978-92-9499-054-9 doi:10.2805/32422 [T] View web page
Freeman, T., P., Van der Pol, P., Kuijpers, W., Wisselink , J., Das, R., K., Rigter, S., Van Laar, M., Griffiths, P., N., Swift, W., Niesink , R. and Lynskey, M. (2018). Changes in cannabis potency and first-time admissions to drug treatment: A 16-year study in the Netherlands. Psychological Medicine, 48, (14). doi:10.1017/S0033291717003877 [RJ] View web page
Gossop, M., Griffiths, P., N., Powis, B. and Strang, J. (2018). Cocaine: Patterns of Use, Route of Administration, and Severity of Dependence. British Journal of Industrial Medicine, 164, (5). doi:10.1192/bjp.164.5.660 [RJ] View web page
Griffiths, P., N., Quigley, E., Vandam, L. and Mounteney, J. (2018). The challenge of responding to a more globally joined-up, dynamic, and innovative drug market: Reflections from the EMCDDA's 2018 analysis of the European drug situation. Dusunen Adam Journal of Psychiatry and Neurological Sciences, 31, (3), pp. 231-237. doi:10.5350/DAJPN20183103001 [RJ] View web page
Hughes, B., Matias, J. and Griffiths, P., N. (2018). Inconsistencies in the assumptions linking punitive sanctions and use of cannabis and new psychoactive substances in Europe. Addiction, 113, (12), pp. 2155-2157. doi:10.1111/add.14372 [RJ] View web page
Kraus, L., Seitz, N., Piontek, D., Molinaro, S., Siciliano, V., Guttormsson, U., Arpa, S., Monshouwer, K., Leifman, H., Vicente, J., Griffiths, P., N., Clancy, L., Feijão, F., Florescu, S., Lambrecht, P., Nociar, A., Raitasalo, K., Spilka , S., Vyshinskiy, K. and Hibell , B. (2018). 'Are The Times A-Changin'? Trends in adolescent substance use in Europe. Addiction, 113, (7), pp. 1317-1332. doi:10.1111/add.14201 [RJ] View web page
Laniel , L., Gandilhon, M., Adès, J., Cunningham, A., Singleton, N., Sedefov, R. and Griffiths, P., N. (2018). EMCDDA Papers Captagon: Understanding today's illicit market. Publications Office of the European Union. ISBN: 978-92-9497-349-8 doi:10.2810/855785 [T] View web page
Peacock, A., Leung, J., Larney, S., Colledge-Frisby, S., Hickman, M., Rehm, J., Giovino, G., A., West, R., Hall, W., Griffiths, P., N., Ali, R., L., Gowing, L., R., Marsden, J., Ferrari, A., J., Grebely, J., Farrell, M. and Degenhardt, L. (2018). Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction, 113, (10), pp. 1905-1926. doi:10.1111/add.14234 [RJ] View web page
Pirona, A., Matias, J., Giraudon , I., Montanari, L., Mounteney, J., Surmont, T., Laniel , L., Wcisło, A., Bo, A., Christie, R., Jekabsone, I., Škařupová, K., Singleton, N. and Griffiths, P., N. (2018). Results from an EMCDDA trendspotter study Recent changes in Europe's cocaine market. Publications Office of the European Union, Luxembourg. doi:10.2810/49990 [T] View web page
Szcześniak, A., Goodey, J., Stanners, D., Ikomonou, D., Mortensen, L., Mezger, E., Comby, B., Griffiths, P., N., Purser, S., Hugas, M., Murphy, T., Ranieri, A., Catchpole, M., Schmidt-Abbey, B., Cockburn, W., Needham, H., Eichler, H., Knight, D. and Deluyker, H. (2018). Approaches to assess and manage scientific uncertainty: examples from EU ANSA agencies. European Food Safety Authority. ISBN: 978-92-9499-059-4 doi:10.2805/936107 [T] View web page
Degenhardt, L., Peacock, A., Colledge-Frisby, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E., B., Trickey, A., Dumchev, K., Lynskey, M., Griffiths, P., N., Mattick, R., Hickman, M. and Larney, S. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. The Lancet Global Health, 5, (12), pp. e1192-e1207. doi:10.1016/S2214-109X(17)30375-3 [RJ] View web page
Griffiths, P., N. and Mounteney, J. (2017). Disruptive Potential of the Internet to Transform Illicit Drug Markets and Impact on Future Patterns of Drug Consumption. Clinical Pharmacology & Therapeutics, 101, (2), pp. 176-178. doi:10.1002/cpt.561 [RJ] View web page
Hughes, B., Quigley, E., Ballotta, D. and Griffiths, P., N. (2017). European observations on cannabis legalization. Addiction, 112, (7), pp. 1136-1137. doi:10.1111/add.13740 [RJ] View web page
Hughes, B., Wiessing , L., Des Jarlais , D., C. and Griffiths, P., N. (2017). Could cannabis liberalisation lead to wider changes in drug policies and outcomes? International Journal of Drug Policy, 51, pp. 156-159. doi:10.1016/j.drugpo.2017.10.004 [RJ] View web page
Larney, S., Peacock, A., Leung, J., Colledge-Frisby, S., Hickman, M., Vickerman, P., Grebely, J., Dumchev, K., Griffiths, P., N., Hines, L., Cunningham, E., B., Mattick, R., Lynskey, M., Marsden, J., Strang, J. and Degenhardt, L. (2017). Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. The Lancet Global Health, 5, (12), pp. e1208-e1220. doi:10.1016/S2214-109X(17)30373-X [RJ] View web page
Lynskey, M., Morley, K., Griffiths, P., N., Gossop, M., Powis, B. and Strang, J. (2017). The relationship between initial route of heroin administration and speed of transition to daily heroin use. Drug and Alcohol Review, 36, (5), pp. 633-638. doi:10.1111/dar.12560 [RJ] View web page
Mounteney, J., Cunningham, A., Groshkova, T., Sedefov, R. and Griffiths, P., N. (2017). Looking to the future-more concern than optimism that cryptomarkets will reduce drug-related harms: Commentary. Addiction, 113, (5), pp. 799-800. doi:10.1111/add.14056 [RJ] View web page
Mounteney, J., Griffiths, P., N., Bo, A., Cunningham, A., Matias, J. and Pirona, A. (2017). Nine reasons why ecstasy is not quite what it used to be. International Journal of Drug Policy, 51, pp. 36-41. doi:10.1016/j.drugpo.2017.09.016 [RJ] View web page
Mounteney, J., Ruiz, M., J., Bo, A., Groshkova, T., Matias, J., Vandam, L., Cardoso, F., Christie, R., Montanari, L., Giraudon , I. and Griffiths, P., N. (2017). High-risk drug use and new psychoactive substances. Results from an EMCDDA trendspotter study. Publications Office of the European Union. ISBN: 978-92-9497-118-0 doi:10.2810/583405 [T] View web page
Vandam, L., Matias, J., McKetin, R., Meacham, M. and Griffiths, P., N. (2017). Illicit Drug Trends Globally. In Quah, S., R. (ed.) International Encyclopedia of Public Health (Second Edition). pp. 146-156. doi:10.1016/B978-0-12-803678-5.00223-X [CH] View web page
Wiessing , L., Ferri, M., Běláčková, V., Carrieri, P., Friedman, S., R., Folch, C., Dolan, K., Galvin, B., Vickerman, P., Lazarus, J., V., Mravčík, V., Kretzschmar, M., Sypsa, V., Sarasa-Renedo, A., Uusküla, A., Paraskevis, D., Mendão, L., Rossi, D., van Gelder , N., Mitcheson, L., Paoli , L., Diaz Gomez, C., Milhet, M., Dascalu, N., Knight, J., Hay, G., Kalamara, E., Simon, R., Comiskey, C., Rossi, C. and Griffiths, P., N. (2017). Monitoring quality and coverage of harm reduction services for people who use drugs: A consensus study. Harm Reduction Journal, 14, (19). doi:10.1186/s12954-017-0141-6 [RJ] View web page
Wiessing , L., Ferri, M., Darke, S., Simon, R. and Griffiths, P., N. (2017). Large variation in measures used to assess outcomes of opioid dependence treatment: A systematic review of longitudinal observational studies. Drug and Alcohol Review, 37, (1), pp. S323-S338. doi:10.1111/dar.12608 [RJ] View web page
Mounteney, J., Griffiths, P., N. and Vandam, L. (2016). What is the future for internet drug markets? In Mounteney, J., Bo, A. and Oteo Pérez, A. (eds.) The internet and drug markets. Publications Office of the European Union, Luxembourg. ISBN: 978-92-9168-841-8 doi:10.2810/324608 [CH] View web page
Mounteney, J., Griffiths, P., N., Cunningham, A., Evans-Brown, M., Ferri, M., Hedrich, D. and Noor, A. (2016). Continued signs of resilience in the European drug market: Highlights from the EMCDDA’s 2016 European drug report. Drugs: Education, Prevention and Policy, 23, (6), pp. 492-495. doi:10.1080/09687637.2016.1243091 [RJ] View web page
Mounteney, J., Griffiths, P., N., Sedefov, R., Noor, A., Vicente, J. and Simon, R. (2016). The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015. Addiction, 111, (1), pp. 34-48. doi:10.1111/add.13056 [RJ] View web page
Mounteney, J., Oteo Pérez, A. and Griffiths, P., N. (2016). The internet and drug markets: shining a light on these complex and dynamic systems. In Mounteney, J., Bo, A. and Oteo Pérez, A. (eds.) The internet and drug markets. Publications Office of the European Union, Luxembourg. ISBN: 978-92-9168-841-8 doi:10.2810/324608 [CH] View web page
Van Buskirk, J., Griffiths, P., N., Farrell, M. and Degenhardt, L. (2016). Trends in new psychoactive substances from surface and "dark" net monitoring. The Lancet Psychiatry, 4, (1), pp. 16-18. doi:10.1016/S2215-0366(16)30405-9 [RJ] View web page
Castiglioni, S., Griffiths, P., N., Kasprzyk-Hordern, B., Me, A. and Thomas, K., V. (2014). Special Issue. Testing the waters: A selection of papers from the first international multidisciplinary conference on detecting illicit drugs in wastewater. Science of The Total Environment, 487, (15), pp. 611-612. doi:10.1016/j.scitotenv.2014.03.130 [RJ] View web page
Griffiths, P., N., Evans-Brown, M. and Sedefov, R. (2014). The (mis)use of psychoactive medicines: getting the balance right in complex systems. Addiction, 109, (2), pp. 182-183. doi:10.1111/add.12306 [RJ] View web page
Hughes, B. and Griffiths, P., N. (2014). Regulatory approaches to new psychoactive substances (NPS) in the European Union. Addiction, 109, (10), pp. 1591-1593. doi:10.1111/add.12610 [RJ] View web page
Lazarus, J., V., Lundgren, J., Casabona, J., Wiessing , L., Matheï, C., Vickerman, P., Prins, M., Kretzschmar, M., Kantzanou, M., Giraudon , I., Ferri, M., Griffiths, P., N., Harris, M., Walker, M., Chavdarova, L., Schatz, E., Schiffer, K., Kools, J., P., Farell, J. and Mendão, L. (2014). Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis. Viral Hepatitis and Drug Use in Europe, 14. doi:10.1186/1471-2334-14-S6-S18 [RJ] View web page
Mounteney, J. and Griffiths, P., N. (2014). Increasing complexity in European drug use: Highlights from the EMCDDA’s 2014 European drug report. Drugs: Education, Prevention and Policy, 21, (6), pp. 482-483. doi:10.3109/09687637.2014.963516 [RJ] View web page
Ort, C., van Nuijs, A., L., Berset, J., Bijlsma, L., Castiglioni, S., Covaci, A., de Voogt, P., Emke, E., Fatta-Kassinos, D., Griffiths, P., N., Hernández, F., González-Mariño, I., Grabic, R., Kasprzyk-Hordern, B., Mastroianni, N., Meierjohann, A., Nefau, T., Östman, M., Pico, Y., Racamonde, I., Reid, M., Slobodnik, J., Terzic, S., Thomaidis, N. and Thomas, K., V. (2014). Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysis. Addiction, 109, (8), pp. 1338-1352. doi:10.1111/add.12570 [RJ] View web page
Castiglioni, S., Thomas, K., V., Kasprzyk-Hordern, B., Vandam, L. and Griffiths, P., N. (2013). Testing wastewater to detect illicit drugs: State of the art, potential and research needs. Science of The Total Environment, 487, (15), pp. 613-620. doi:10.1016/j.scitotenv.2013.10.034 [RJ] View web page
Griffiths, P., N., Evans-Brown, M. and Sedefov, R. (2013). Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age. Addiction, 108, (10), pp. 1700-1703. doi:10.1111/add.12287 [RJ] View web page
Mounteney, J., Zobel, F. and Griffiths, P., N. (2013). The European drug landscape in 2013 – Highlights from the EMCDDA's European drug report. Drugs: Education, Prevention and Policy, 20, (5), pp. 425-426. doi:10.3109/09687637.2013.832544 [RJ] View web page
Parrott, A., C., Corazza, O., Schifano, F., Griffiths, P., N., Sedefov, R., Gallegos, A., Murray, R., M., Demetrovics, Z., Curran, V., Bersani, G. and Singer, L., T. (2013). Editorial: Second International Conference on Novel Psychoactive Substances (NPSs): Keynote Addresses and Conference Abstracts. Current Drug Abuse Reviews, 6, (4), pp. 255-256. doi:10.2174/187447370604140616121012 [RJ] View web page
Griffiths, P., N., Mounteney, J. and Laniel , L. (2012). Understanding changes in heroin availability in Europe over time: emerging evidence for a slide, a squeeze and a shock. Addiction, 107, (9), pp. 1539-1540. doi:10.1111/j.1360-0443.2012.03829.x [RJ] View web page
Griffiths, P., N., Mounteney, J., Lopez, D., Zobel, F. and Götz, W. (2012). Addiction Research Centres and the Nurturing of Creativity. Monitoring the European drug situation: the ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Addiction, 107, (2), pp. 254-258. doi:10.1111/j.1360-0443.2011.03369.x [RJ] View web page
Mena, G., Giraudon , I., Álvarez, E., Corkery, J., M., Matias, J., Grasaasen, K., Llorens, N., Griffiths, P., N. and Vicente, J. (2012). Cocaine-Related Health Emergencies in Europe: A Review of Sources of Information, Trends and Implications for Service Development. European Addiction Research, 19, (2), pp. 74-81. doi:10.1159/000341719 [RJ] View web page
Pharris, A., Wiessing , L., Sfetcu, O., Hedrich, D., Botescu, A., Fotiou, A., Nikolopoulos, G., K., Malliori, M., Salminen, M., Suk, J., E., Griffiths, P., N. and van de Laar, M., J. (2011). Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. Eurosurveillance, 16, (48). doi:10.2807/ese.16.48.20032-en [RJ] View web page
Davoli, M., Simon, R. and Griffiths, P., N. (2010). Current and future perspectives on harm reduction in the European Union. In Rhodes, T. and Hedrich, D. (eds.) Harm reduction: evidence, impacts and challenges. Publications Office of the European Union, Luxembourg. pp. 437-446. ISBN: 978-92-9168-419-9 doi:10.2810/29497 [CH] View web page
Griffiths, P., N., Lopez, D., Sedefov, R., Gallegos, A., Hughes, B., Noor, A. and Royuela, L. (2010). Khat use and monitoring drug use in Europe: The current situation and issues for the future. Journal of Ethnopharmacology, 132, (3), pp. 578-583. doi:10.1016/j.jep.2010.04.046 [RJ] View web page
Griffiths, P., N., Sedefov, R., Gallegos, A. and Lopez, D. (2010). How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case study. Addiction, 105, (6), pp. 951-953. doi:10.1111/j.1360-0443.2009.02874.x [RJ] View web page
Muscat, R., Carter, A., Griffiths, P., N., Lopez, D. and Hall, W. (2009). General introduction. In Carter, A., Capps, B. and Hall, W. (eds.) Addiction neurobiology: Ethical and social implications. Office for Official Publications of the European Communities, Luxembourg. pp. 17-19. ISBN: 978–92–9168–347–5 doi:10.2810/48676 [CH] View web page
Wiessing , L., Likatavičius, G., Klempová, D., Hedrich, D., Nardone, A. and Griffiths, P., N. (2009). Associations Between Availability and Coverage of HIV-Prevention Measures and Subsequent Incidence of Diagnosed HIV Infection Among Injection Drug Users. American Journal of Public Health, 99, pp. 1049-1052. doi:10.2105/AJPH.2008.141846 [RJ] View web page
Wiessing , L., Olszewski, D., Klempova, D., Vicente, J. and Griffiths, P., N. (2009). EMCDDA Annual report 2009: cocaine and heroin maintain firm hold on Europe’s drug scene. Eurosurveillance, 14, (46). doi:10.2807/ese.14.46.19410-en [RJ] View web page
Frost, N., Griffiths, P., N. and Fanelli, R. (2008). Peering into dirty waters: the potential and implications of a new approach to monitoring drug consumption. Addiction, 103, (8), pp. 1239-1241. doi:10.1111/j.1360-0443.2008.02204.x [RJ] View web page
Griffiths, P., N., Dominique, L. and Götz, W. (2008). Monitoring trends in illicit drug use in Europe: an overview of the work of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Psychiatrie und Psychotherapie, 4, pp. 58-65. doi:10.1007/s11326-008-0014-4 [RJ] View web page
Griffiths, P., N., Mravčík, V., Lopez, D. and Klempova, D. (2008). Quite a lot of smoke but very limited fire—the use of methamphetamine in Europe. Drug and Alcohol Review, 27, (3), pp. 236-242. doi:10.1080/09595230801932588 [RJ] View web page
Morgan, O., Vicente, J., Griffiths, P., N. and Hickman, M. (2008). Trends in overdose deaths from drug misuse in Europe: what do the data tell us? Addiction, 103, (5), pp. 699-700. doi:10.1111/j.1360-0443.2007.02102.x [RJ] View web page
Wiessing , L., van de Laar, M., J., Donoghoe, M., Guarita, B., Klempova, D. and Griffiths, P., N. (2008). HIV among injecting drug users in Europe: increasing trends in the East. Eurosurveillance, 13, (50). doi:10.2807/ese.13.50.19067-en [RJ] View web page
Griffiths, P., N. and McKetin, R. (2005). A Common Language for a Common Problem: The Developing Role of Drug Epidemiology in a Global Context. In Sloboda, Z. (ed.) Epidemiology of Drug Abuse. pp. 161-176. doi:10.1007/0-387-24416-6_11 [CH] View web page
King, L., A., Carpentier, C. and Griffiths, P., N. (2005). Cannabis potency in Europe. Addiction, 100, (7), pp. 884-886. doi:10.1111/j.1360-0443.2005.001137.x [RJ] View web page
King, L., A., Carpentier, C. and Griffiths, P., N. (2005). Getting the facts right: A reply to Smith (2005). Addiction, 100, (10), pp. 1560-1561. doi:10.1111/j.1360-0443.2005.01282.x [RJ] View web page
Marsden, J., Boys, A., Farrell, M., Stillwell, G., Hutchings, K., Hillebrand, J. and Griffiths, P., N. (2005). Personal and social correlates of alcohol consumption among mid-adolescents. British Journal of Developmental Psychology, 23, (3), pp. 427-450. doi:10.1348/026151005X26020 [RJ] View web page
Taylor, C. and Griffiths, P., N. (2005). Sampling Issues in Drug Epidemiology. In Sloboda, Z. (ed.) Epidemiology of Drug Abuse. pp. 79-98. doi:10.1007/0-387-24416-6_6 [CH] View web page
King, L., A., Carpentier, C. and Griffiths, P., N. (2004). An overview of cannabis potency in Europe. Office for Official Publications of the European Communities, Luxembourg. ISBN: 92-9168-184-9 [M] View web page
Wiessing , L., Ncube, F., Hedrich, D., Griffiths, P., N., Hope, V., Gill, N., Hamers, F., F., de la Fuente, L., Klavs, I., Leinikki, P., Blystad, H., Meheus, A., Rezza, G., Stimson, G. and Goldberg, D. (2004). Surveillance of infectious diseases in IDUs across the EU: information from the EU expert network. Eurosurveillance, 8, (4). doi:10.2807/esw.08.04.02368-en [RJ] View web page
Boys, A., Marsden, J., Stillwell, G., Hatchings, K., Griffiths, P., N. and Farrell, M. (2003). Minimizing respondent attrition in longitudinal research: Practical implications from a cohort study of adolescent drinking. Journal of Adolescence, 26, (3), pp. 363-373. doi:10.1016/S0140-1971(03)00011-3 [RJ] View web page
Griffiths, P., N. and McKetin, R. (2003). Developing a global perspective on drug consumption patterns and trends - The challenge for drug epidemiology. In Chawla, S. (ed.) Bulletin on Narcotics, LV, (1), pp. 1-8. United Nations Office on Drugs and Crime, Vienna. [CH] Download PDF
McKetin, R. and Griffiths, P., N. (2003). Developing a global perspective on drug information systems. Drug and Alcohol Review, 22, (4), pp. 387-389. doi:10.1080/09595230310001613895 [RJ] View web page
Shand, F., Topp, L., Darke, S., Makkai, T. and Griffiths, P., N. (2003). The monitoring of drug trends in Australia. Drug and Alcohol Review, 22, (1), pp. 61-72. doi:10.1080/0959523021000059848 [RJ] View web page
Strang, J., Gossop, M., Griffiths, P., N. and Powis, B. (2003). HIV among south London heroin users in 1991. The Lancet, 339, (8800), pp. 1060-1061. doi:10.1016/0140-6736(92)90587-S [RJ] View web page
Wiessing , L., Hedrich, D., Taylor, C. and Griffiths, P., N. (2003). Hepatitis C: A hidden epidemic. Office for Official Publications of the European Communities. [UP] View web page
Hickman, M., Taylor, C., Chatterjee, A., Degenhardt, L., Frischer, M., Hay, G., Tilling, K., Wiessing , L., Griffiths, P., N. and McKetin, R. (2002). Estimating the prevalence of problematic drug use: a review of methods and their application. In Chawla, S. (ed.) Bulletin on Narcotics, LIV, (1), pp. 15-32. United Nations Office on Drugs and Crime, Vienna. ISBN: 92-1-148170-8 [CH] Download PDF
Strang, J., Powis, B., Best, D., Vingeo, L., Griffiths, P., N., Taylor, C., Welch, S. and Gossop, M. (2002). Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction, 94, (2), pp. 199-204. doi:10.1046/j.1360-0443.1999.9421993.x [RJ] View web page
Winstock, A., R., Griffiths, P., N. and Stewart, D. (2001). Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug and Alcohol Dependence, 64, (1), pp. 9-17. doi:10.1016/S0376-8716(00)00215-5 [RJ] View web page
Boys, A., Marsden, J., Griffiths, P., N. and Strang, J. (2000). Drug use functions predict cocaine-related problems in young people. Drug and Alcohol Review, 19, (2), pp. 181-190. doi:10.1080/713659316 [RJ] View web page
Farrell, M., Neeleman, J., Gossop, M., Griffiths, P., N., Finch, E. and Strang, J. (2000). Delivery of methadone maintenance in the European union. European Psychiatry, 11, pp. 234s. doi:10.1016/0924-9338(96)88700-1 [RJ] View web page
Fountain, J., Strang, J., Gossop, M., Farrell, M. and Griffiths, P., N. (2000). Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London. Addiction, 95, (3), pp. 393-406. doi:10.1046/j.1360-0443.2000.95339310.x [RJ] View web page
Fountain, J., Strang, J., Griffiths, P., N., Powis, B. and Gossop, M. (2000). Measuring Met and Unmet Need of Drug Misusers: Integration of Quantitative and Qualitative Data. European Addiction Research, 6, (2), pp. 97-103. doi:10.1159/000019017 [RJ] View web page
Griffiths, P., N., Vingeo, L., Hunt, N., Mounteney, J. and Hartnoll, R. (2000). Drug Information Systems, Early Warning, and New Drug Trends: Can Drug Monitoring Systems Become More Sensitive to Emerging Trends in Drug Consumption? Substance Use and Misuse, 35, (6), pp. 811-844. doi:10.3109/10826080009148423 [RJ] View web page
Marsden, J., Stewart, D., Gossop, M., Rolfe, A., Bacchus, L., Griffiths, P., N., Clarke, K. and Strang, J. (2000). Assessing Client Satisfaction with Treatment for Substance Use Problems and the Development of the Treatment Perceptions Questionnaire (TPQ). Addiction Research, 8, (5), pp. 455-470. doi:10.3109/16066350009005590 [RJ] View web page
Powis, B., Gossop, M., Bury, C., Payne, K. and Griffiths, P., N. (2000). Drug-using mothers: social, psychological and substance use problems of women opiate users with children. Drug and Alcohol Review, 19, (2), pp. 171-180. doi:10.1080/713659321 [RJ] View web page
Boys, A., Marsden, J., Fountain, J., Griffiths, P., N., Stillwell, G. and Strang, J. (1999). What Influences Young People's Use of Drugs? A qualitative study of decision-making. Drugs: Education, Prevention and Policy, 6, (3), pp. 373-387. doi:10.1080/09687639997052 [RJ] View web page
Boys, A., Marsden, J., Griffiths, P., N., Fountain, J., Stillwell, G. and Strang, J. (1999). Substance use among young people: the relationship between perceived functions and intentions. Addiction, 94, (7), pp. 1043-1050. doi:10.1046/j.1360-0443.1999.94710439.x [RJ] View web page
Fountain, J. and Griffiths, P., N. (1999). Synthesis of Qualitative Research on Drug Use in the European Union: Report on an EMCDDA Project. European Addiction Research, 5, (1), pp. 4-20. doi:10.1159/000018959 [RJ] View web page
Fountain, J., Bartlett, H., Griffiths, P., N., Gossop, M., Boys, A. and Strang, J. (1999). Why Say No? Reasons Given by Young People for Not Using Drugs. Addiction Research, 7, (4), pp. 339-353. doi:10.3109/16066359909004391 [RJ] View web page
Hunt, N., Griffiths, P., N., Southwell, M., Stillwell, G. and Strang, J. (1999). Preventing and curtailing injecting drug use: a review of opportunities for developing and delivering 'route transition interventions'. Drug and Alcohol Review, 18, (4), pp. 441-451. doi:10.1080/09595239996310 [RJ] View web page
Powis, B., Strang, J., Griffiths, P., N., Taylor, C., Williamson, S., Fountain, J. and Gossop, M. (1999). Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction, 94, (4), pp. 471-478. doi:10.1046/j.1360-0443.1999.9444712.x [RJ] View web page
Stillwell, G., Hunt, N., Taylor, C. and Griffiths, P., N. (1999). The Modelling of Injecting Behaviour and Initiation into Injecting. Addiction Research, 7, (5), pp. 447-459. doi:10.3109/16066359909004398 [RJ] View web page
Strang, J., Griffiths, P., N., Powis, B. and Gossop, M. (1999). Heroin Chasers and Heroin Injectors: Differences Observed in a Community Sample in London, UK. The American Journal on Addictions, 8, (2), pp. 148-160. doi:10.1080/105504999305956 [RJ] View web page
Strang, J., Griffiths, P., N., Powis, B., Abbey, J. and Gossop, M. (1999). How constant is an individual's route of heroin administration?: Data from treatment and non-treatment samples. Drug and Alcohol Dependence, 46, (1), pp. 115-118. doi:10.1016/S0376-8716(97)00035-5 [RJ] View web page
Strang, J., Griffiths, P., N., Powis, B., Abbey, J. and Gossop, M. (1999). How constant is an individual's route of heroin administration?: Data from treatment and non-treatment samples. Drug and Alcohol Dependence, 46, (1), pp. 115-118. doi:10.1016/S0376-8716(99)00101-5 [RJ] View web page
Strang, J., Griffiths, P., N., Powis, B., Fountain, J., Williamson, S. and Gossop, M. (1999). Which drugs cause overdose among opiate misusers? Study of personal and witnessed overdoses. Drug and Alcohol Review, 18, (3), pp. 253-261. doi:10.1080/09595239996383 [RJ] View web page
Williamson, S., Gossop, M., Powis, B., Griffiths, P., N., Fountain, J. and Strang, J. (1999). Adverse effects of stimulant drugs in a community sample of drug users. Drug and Alcohol Dependence, 44, (2), pp. 87-94. doi:10.1016/S0376-8716(96)01324-5 [RJ] View web page
Fountain, J., Griffiths, P., N., Farrell, M., Gossop, M. and Strang, J. (1998). Diversion tactics: how a sample of drug misusers in treatment obtained surplus drugs to sell on the illicit market. International Journal of Drug Policy, 9, (3), pp. 159-167. doi:10.1016/S0955-3959(98)00013-9 [RJ] View web page
Hunt, N., Stillwell, G., Taylor, C. and Griffiths, P., N. (1998). Evaluation of a Brief Intervention to Prevent Initiation into Injecting. Drugs: Education, Prevention and Policy, 5, (2), pp. 185-194. doi:10.3109/09687639809006684 [RJ] View web page
Lloyd, C. and Griffiths, P., N. (1998). Editorial: Problems for the future? Drug use among vulnerable groups of young people. Drugs: Education, Prevention and Policy, 5, (3), pp. 213-216. doi:10.3109/09687639809034083 [RJ] View web page
Marsden, J., Griffiths, P., N., Farrell, M., Gossop, M. and Strang, J. (1998). Cocaine in Britain: Prevalence, Problems, and Treatment Responses. Journal of Drug Issues, 28, (1), pp. 225-241. doi:10.1177/002204269802800113 [RJ] View web page
Powis, B., Griffiths, P., N., Gossop, M., Lloyd, C. and Strang, J. (1998). Drug Use and Offending Behaviour Among Young People Excluded from School. Drugs: Education, Prevention and Policy, 5, (3), pp. 245-256. doi:10.3109/09687639809034086 [RJ] View web page
Strang, J., Bearn, J., Farrell, M., Finch, E., Gossop, M., Griffiths, P., N., Marsden, J. and Wolff, K. (1998). Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug and Alcohol Review, 17, (2), pp. 197-211. doi:10.1080/09595239800187001 [RJ] View web page
Gossop, M., Griffiths, P., N., Powis, B., Williamson, S., Fountain, J. and Strang, J. (1997). Continuing drug risk behaviour: Shared use of injecting paraphernalia among London heroin injectors. AIDS Care, 9, (6), pp. 651-660. doi:10.1080/09540129750124687 [RJ] View web page
Griffiths, P., N., Gossop, M., Wickenden, S., Dunworth, J., Harris, K. and Lloyd, C. (1997). A transcultural pattern of drug use: Qat (khat) in the UK. British Journal of Psychiatry, 170, (3), pp. 281-284. doi:10.1192/bjp.170.3.281 [RJ] View web page
Strang, J., Griffiths, P., N. and Gossop, M. (1997). Chasing the elusive dragon: the need for better definition. Addiction, 92, (6), pp. 692-695. doi:10.1111/j.1360-0443.1997.tb02935.x [RJ] View web page
Strang, J., Griffiths, P., N. and Gossop, M. (1997). Heroin in the United Kingdom: different forms, different origins, and the relationship to different routes of administration. Drug and Alcohol Review, 16, (4), pp. 329-337. doi:10.1080/09595239700186711 [RJ] View web page
Strang, J., Griffiths, P., N. and Gossop, M. (1997). Heroin smoking by ‘chasing the dragon’: origins and history. Addiction, 92, (6), pp. 673-683. doi:10.1111/j.1360-0443.1997.tb02927.x [RJ] View web page
Farrell, M., Neeleman, J., Griffiths, P., N. and Strang, J. (1996). Suicide and overdose among opiate addicts. Addiction, 91, (3), pp. 321-323. doi:10.1080/09652149640428 [RJ] View web page
Gossop, M., Griffiths, P., N., Powis, B., Williamson, S. and Strang, J. (1996). Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. British Medical Journal, 313, pp. 402. doi:10.1136/bmj.313.7054.402 [RJ] View web page
Powis, B., Griffiths, P., N., Gossop, M. and Strang, J. (1996). The Differences between Male and Female Drug Users: Community Samples of Heroin and Cocaine Users Compared. Substance Use and Misuse, 31, (5), pp. 529-543. doi:10.3109/10826089609045825 [RJ] View web page
Gossop, M., Darke, S., Griffiths, P., N., Hando, J., Powis, B., Hall, W. and Strang, J. (1995). The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90, (5), pp. 607-614. doi:10.1046/j.1360-0443.1995.9056072.x [RJ] View web page
Gossop, M., Powis, B., Griffiths, P., N. and Strang, J. (1995). Female prostitutes in south London: Use of heroin, cocaine and alcohol, and their relationship to health risk behaviours. AIDS Care, 7, (3), pp. 253-260. doi:10.1080/09540129550126498 [RJ] View web page
Powis, B., Griffiths, P., N., Gossop, M. and Strang, J. (1995). Heterosexual anal intercourse, health risks and drug use: a review with special attention to drug users. Drug and Alcohol Review, 14, (2), pp. 223-229. doi:10.1080/09595239500185281 [RJ] View web page
Gossop, M., Griffiths, P., N. and Strang, J. (1994). Sex Differences in Patterns of Drug Taking Behaviour. British Journal of Psychiatry, 164, (1), pp. 101-104. doi:10.1192/bjp.164.1.101 [RJ] View web page
Gossop, M., Powis, B., Griffiths, P., N. and Strang, J. (1994). Multiple risks for HIV and hepatitis B infection among heroin users. Drug and Alcohol Review, 13, (3), pp. 293-300. doi:10.1080/09595239400185391 [RJ] View web page
Gossop, M., Powis, B., Griffiths, P., N. and Strang, J. (1994). Sexual behaviour and its relationship to drug-taking among prostitutes in south London. Addiction, 89, (8), pp. 961-970. doi:10.1111/j.1360-0443.1994.tb03356.x [RJ] View web page
Gossop, M., Strang, J., Griffiths, P., N., Powis, B. and Taylor, C. (1994). A Ratio Estimation Method for Determining the Prevalence of Cocaine Use. British Journal of Psychiatry, 164, (5), pp. 676-679. doi:10.1192/bjp.164.5.676 [RJ] View web page
Griffiths, P., N., Gossop, M., Powis, B. and Strang, J. (1994). Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction, 89, (3), pp. 301-309. doi:10.1111/j.1360-0443.1994.tb00896.x [RJ] View web page
Strang, J., Griffiths, P., N., Abbey, J. and Gossop, M. (1994). Survey of use of injected benzodiazepines among drug users in Britain. British Medical Journal, 308, pp. 1082. doi:10.1136/bmj.308.6936.1082 [RJ] View web page
Strang, J., Powis, B., Griffiths, P., N. and Gossop, M. (1994). Heterosexual Vaginal and Anal Intercourse Amongst London Heroin and Cocaine Users. International Journal of STD & AIDS, 5, (2), pp. 133-136. doi:10.1177/095646249400500211 [RJ] View web page
Gossop, M., Griffiths, P., N., Powis, B. and Strang, J. (1993). Severity of heroin dependence and HIV risk. I. Sexual behaviour. AIDS Care, 5, (2), pp. 149-157. doi:10.1080/09540129308258595 [RJ] View web page
Gossop, M., Griffiths, P., N., Powis, B. and Strang, J. (1993). Severity of heroin dependence and HIV risk. II. Sharing injecting equipment. AIDS Care, 5, (2), pp. 159-168. doi:10.1080/09540129308258596 [RJ] View web page
Griffiths, P., N., Gossop, M., Powis, B. and Strang, J. (1993). Reaching hidden populations of drug users by privileged access interviewers: methodological and practical issues. Addiction, 88, (12), pp. 1617-1626. doi:10.1111/j.1360-0443.1993.tb02036.x [RJ] View web page
Dawe, S., Griffiths, P., N., Gossop, M. and Strang, J. (1992). Should opiate addicts be involved in controlling their own detoxification? A comparison of fixed versus negotiable schedules. British Journal of Addiction, 87, (8), pp. 1221. doi:10.1111/j.1360-0443.1992.tb02012.x [RJ] View web page
Gossop, M., Griffiths, P., N., Powis, B. and Strang, J. (1992). Severity of dependence and route of administration of heroin, cocaine and amphetamines. British Journal of Addiction, 87, (11), pp. 1527-1536. doi:10.1111/j.1360-0443.1992.tb02660.x [RJ] View web page
Griffiths, P., N., Gossop, M., Powis, B. and Strang, J. (1992). Extent and nature of transitions of route among heroin addicts in treatment—preliminary data from the Drug Transitions Study. British Journal of Addiction, 87, (3), pp. 485-491. doi:10.1111/j.1360-0443.1992.tb01949.x [RJ] View web page
Strang, J., Des Jarlais , D., C., Griffiths, P., N. and Gossop, M. (1992). The study of transitions in the route of drug use: the route from one route to another. British Journal of Addiction, 87, (3), pp. 473-483. doi:10.1111/j.1360-0443.1992.tb01948.x [RJ] View web page
Strang, J., Griffiths, P., N., Powis, B. and Gossop, M. (1992). First use of heroin: changes in route of administration over time. British Medical Journal, 304, pp. 1222. doi:10.1136/bmj.304.6836.1222 [RJ] View web page
Kasvikis, Y., Bradley, B., Gossop, M., Griffiths, P., N. and Marks, I. (1990). Clonidine Versus Long- and Short-Term Methadone-Aided Withdrawal from Opiates. An Uncontrolled Comparison. International Journal of the Addictions, 25, (10), pp. 1169-1178. doi:10.3109/10826089009058878 [RJ] View web page
Strang, J., Griffiths, P., N. and Gossop, M. (1990). Crack and cocaine use in South London drug addicts: 1987–1989. British Journal of Addiction, 85, (2), pp. 193-196. doi:10.1111/j.1360-0443.1990.tb03070.x [RJ] View web page
Gossop, M., Griffiths, P., N., Bradley, B. and Strang, J. (1989). Opiate Withdrawal Symptoms in Response to 10-Day and 21-Day Methadone Withdrawal Programmes. British Journal of Psychiatry, 154, (3), pp. 360-363. doi:10.1192/bjp.154.3.360 [RJ] View web page
Strang, J., Gossop, M., Griffiths, P., N. and Farrell, M. (1989). The Technology of Dragon Chasing. British Journal of Addiction, 84, (6), pp. 699. doi:10.1111/j.1360-0443.1989.tb03490.x [RJ] View web page
Gossop, M., Griffiths, P., N. and Strang, J. (1988). Chasing the Dragon: characteristics of heroin chasers. British Journal of Addiction, 83, (10), pp. 1159-1162. doi:10.1111/j.1360-0443.1988.tb03022.x [RJ] View web page
Griffiths, P., N., Wells, B., Strang, J. and Gossop, M. (1988). Changes in Methadone Withdrawal Doses Over a Five Year Period: (1982 to 1986). British Journal of Addiction, 83, (2), pp. 189-191. doi:10.1111/j.1360-0443.1988.tb03980.x [RJ] View web page